{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T18:41:00Z","timestamp":1769884860123,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2024.126574","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T04:50:27Z","timestamp":1733547027000},"page":"126574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A neuraminidase-based inactivated influenza virus vaccine significantly reduced virus replication and pathology following homologous challenge in swine"],"prefix":"10.1016","volume":"46","author":[{"given":"Bryan S.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine K.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Brian","family":"Kimble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan Wymore","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tavis K.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip C.","family":"Gauger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126574_bb0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1099\/0022-1317-33-1-159","article-title":"Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action","volume":"33","author":"Palese","year":"1976","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0042-6822(74)90276-1","article-title":"Characterization of temperature sensitive influenza virus mutants defective in neuraminidase","volume":"61","author":"Palese","year":"1974","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.126574_bb0015","article-title":"A beneficiary role for neuraminidase in influenza virus penetration through the respiratory mucus","volume":"9","author":"Yang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2024.126574_bb0020","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","article-title":"Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium","volume":"78","author":"Matrosovich","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/zph.12049","article-title":"Review of influenza a virus in swine worldwide: a call for increased surveillance and research","volume":"61","author":"Vincent","year":"2014","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.vaccine.2024.126574_bb0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza a viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol Rev"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2024.126574_bb0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/irv.12193","article-title":"Population dynamics of cocirculating swine influenza a viruses in the United States from 2009 to 2012","volume":"7","author":"Anderson","year":"2013","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2024.126574_bb0040","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1099\/vir.0.045930-0","article-title":"Genomic reassortment of influenza a virus in North American swine, 1998-2011","volume":"93","author":"Nelson","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0045","article-title":"Influenza a virus vaccines for swine","author":"Vincent","year":"2016","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0050","first-page":"173","article-title":"Swine influenza virus vaccines: to change or not to change-that\u2019s the question","volume":"370","author":"Van Reeth","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0055","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.vaccine.2011.01.082","article-title":"Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus","volume":"29","author":"Gauger","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126574_bb0060","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1016\/j.vaccine.2022.07.042","article-title":"Bivalent hemagglutinin and neuraminidase influenza replicon particle vaccines protect pigs against influenza a virus without causing vaccine associated enhanced respiratory disease","volume":"40","author":"Wymore Brand","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126574_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz017","article-title":"Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection","author":"Eichelberger","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126574_bb0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coi.2018.03.025","article-title":"Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness","volume":"53","author":"Eichelberger","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/infdis\/129.4.411","article-title":"Induction of partial immunity to influenza by a neuraminidase-specific vaccine","volume":"129","author":"Couch","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126574_bb0080","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126574_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"MBio"},{"issue":"417\u2013429","key":"10.1016\/j.vaccine.2024.126574_bb0090","article-title":"Influenza infection in humans induces broadly Cross-reactive and protective neuraminidase-reactive antibodies","volume":"173","author":"Chen","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2024.126574_bb0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/jvi.2.4.281-288.1968","article-title":"Antiviral activity of antiserum specific for an influenza virus neuraminidase","volume":"2","author":"Kilbourne","year":"1968","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0100","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/JVI.02275-15","article-title":"Hemagglutinin stalk- and neuraminidase-specific monoclonal antibodies protect against lethal H10N8 influenza virus infection in mice","volume":"90","author":"Wohlbold","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0105","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41564-017-0011-8","article-title":"Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes","volume":"2","author":"Wohlbold","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0110","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","article-title":"Effect of neuraminidase antibody on Hong Kong influenza","volume":"1","author":"Monto","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126574_bb0115","first-page":"425","article-title":"The antigenic relationship of the neuraminidase of Hong Kong virus to that of other human strains of influenza a virus","volume":"41","author":"Schulman","year":"1969","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2024.126574_bb0120","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1086\/657084","article-title":"Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza a(H1N1) 2009 virus in an age-dependent manner","volume":"202","author":"Marcelin","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126574_bb0125","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126574_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of Antihemagglutinin and Antineuraminidase antibodies as correlates of protection in an influenza a\/H1N1 virus healthy human challenge model","volume":"7","author":"Memoli","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2024.126574_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-019-0401-1","article-title":"Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza a virus","author":"Yasuhara","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0140","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01667-19","article-title":"Fcgamma receptors contribute to the antiviral properties of influenza virus neuraminidase-specific antibodies","volume":"10","author":"Job","year":"2019","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2024.126574_bb0145","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1128\/JVI.73.10.8851-8856.1999","article-title":"Genetic reassortment of avian, swine, and human influenza a viruses in American pigs","volume":"73","author":"Zhou","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virusres.2004.02.015","article-title":"Multiple lineages of antigenically and genetically diverse influenza a virus co-circulate in the United States swine population","volume":"103","author":"Webby","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2024.126574_bb0155","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1128\/JCM.41.7.3198-3205.2003","article-title":"Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States","volume":"41","author":"Richt","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0160","article-title":"Regional patterns of genetic diversity in swine influenza a viruses in the United States from 2010 to 2016","author":"Walia","year":"2018","journal-title":"Influenza Other Respi Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126574_bb0165","doi-asserted-by":"crossref","first-page":"veab090","DOI":"10.1093\/ve\/veab090","article-title":"Spatial and temporal coevolution of N2 neuraminidase and H1 and H3 hemagglutinin genes of influenza A virus in US swine","volume":"7","author":"Zeller","year":"2021","journal-title":"Virus Evol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0170","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00632-21","article-title":"Evolution and antigenic advancement of N2 neuraminidase of swine influenza a viruses circulating in the United States following two separate introductions from human seasonal viruses","volume":"95","author":"Kaplan","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0175","series-title":"A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses mSphere","first-page":"1","author":"Anderson","year":"2016"},{"key":"10.1016\/j.vaccine.2024.126574_bb0180","article-title":"Antigenic evolution of H3N2 influenza a viruses in swine in the United States from 2012 to 2016","author":"Bolton","year":"2018","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2024.126574_bb0185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.vetmic.2009.01.003","article-title":"Characterization of an influenza a virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States","volume":"137","author":"Vincent","year":"2009","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0190","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1750-2659.2009.00094.x","article-title":"A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens","volume":"3","author":"Sandbulte","year":"2009","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2024.126574_bb0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-1-0716-0346-8_22","article-title":"Enzyme-linked immunosorbent assay for detection of serum or mucosal isotype-specific IgG and IgA whole-virus antibody to influenza a virus in swine","volume":"2123","author":"Gauger","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0200","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/0300985812439724","article-title":"Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) a\/H1N1 influenza virus","volume":"49","author":"Gauger","year":"2012","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0205","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1016\/j.vaccine.2018.08.072","article-title":"The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease","volume":"36","author":"Souza","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126574_bb0210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-2659.2011.00304.x","article-title":"Influenza neuraminidase","volume":"6","author":"Air","year":"2012","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2024.126574_bb0215","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1038\/s41467-019-11296-5","article-title":"Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans","volume":"10","author":"Khurana","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.126574_bb0220","article-title":"Potential antigenic mismatch of the H3N2 component of the 2019 southern hemisphere influenza vaccine","author":"Gouma","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126574_bb0225","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/infdis\/jiw479","article-title":"Antibodies against the current influenza a(H1N1) vaccine strain do not protect some individuals from infection with contemporary circulating influenza a(H1N1) virus strains","volume":"214","author":"Petrie","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126574_bb0230","doi-asserted-by":"crossref","first-page":"15798","DOI":"10.1073\/pnas.1409171111","article-title":"Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season","volume":"111","author":"Linderman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2024.126574_bb0235","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.20130212","article-title":"Immune history shapes specificity of pandemic H1N1 influenza antibody responses","volume":"210","author":"Li","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.126574_bb0240","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12217","article-title":"The global antigenic diversity of swine influenza a viruses","volume":"5","author":"Lewis","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.vaccine.2024.126574_bb0245","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1128\/JVI.01675-15","article-title":"Novel Reassortant human-like H3N2 and H3N1 influenza a viruses detected in pigs are virulent and antigenically distinct from swine viruses endemic to the United States","volume":"89","author":"Rajao","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0250","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01323-18","article-title":"Comparison of Adjuvanted-whole inactivated virus and live-attenuated virus vaccines against challenge with contemporary, antigenically distinct H3N2 influenza a viruses","volume":"92","author":"Abente","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0255","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.vaccine.2018.12.071","article-title":"Alphavirus-vectored hemagglutinin subunit vaccine provides partial protection against heterologous challenge in pigs","volume":"37","author":"Abente","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126574_bb0260","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01006-18","article-title":"Neuraminidase-inhibiting antibody titers correlate with protection from heterologous influenza virus strains of the same neuraminidase subtype","volume":"92","author":"Walz","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0265","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2016.06.001","article-title":"Neuraminidase inhibiting antibody responses in pigs differ between influenza a virus N2 lineages and by vaccine type","volume":"34","author":"Sandbulte","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126574_bb0270","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02281-16","article-title":"Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by ELISA and Enzyme inhibition: evidence for original antigenic sin","volume":"8","author":"Rajendran","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2024.126574_bb0275","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1016\/j.vaccine.2023.10.005","article-title":"Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection","volume":"41","author":"Kitikoon","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126574_bb0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41541-023-00620-2","article-title":"Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs","volume":"8","author":"Vatzia","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2024.126574_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.915364","article-title":"A novel neuraminidase virus-like particle vaccine offers protection against heterologous H3N2 influenza virus infection in the porcine model","volume":"13","author":"Pliasas","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.126574_bb0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0042-6822(84)90114-4","article-title":"Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies","volume":"135","author":"Webster","year":"1984","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.126574_bb0295","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0042-6822(85)90157-6","article-title":"Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase","volume":"145","author":"Air","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.126574_bb0300","doi-asserted-by":"crossref","first-page":"20748","DOI":"10.1073\/pnas.1113801108","article-title":"Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses","volume":"108","author":"Sandbulte","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2024.126574_bb0305","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1099\/vir.0.043059-0","article-title":"Genetic evolution of the neuraminidase of influenza a (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution","volume":"93","author":"Westgeest","year":"2012","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24012568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T16:30:50Z","timestamp":1737304250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24012568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":61,"alternative-id":["S0264410X24012568"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126574","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A neuraminidase-based inactivated influenza virus vaccine significantly reduced virus replication and pathology following homologous challenge in swine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126574"}}